EQHQ
Login
EQHQ
Search your stocks
Login
Command Palette
Search for a command to run...
Explore
Watchlists
Chat
Portfolio
Share
Profile
COHANCE
Overview
Shareholding
Peers
Financials
Ratios
Concall
Feed
Documents
COHANCE
Cohance Lifesciences Ltd.
916.2
(+0.38%)
1W: -10.50%
1M: -5.09%
1Y: +36.28%
Ratios
Cash Conversion Cycle
Latest:
50.0 days
Return on Equity
Latest:
14.2%
Return on Capital Employed
Latest:
18.4%
Dupont Analysis
Analysis Summary
Metric
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
ROE
44.58%
35.78%
33.52%
25.21%
15.87%
14.20%
PAT margin
22.37%
28.56%
30.69%
34.37%
35.89%
38.02%
Asset Turnover
0.79x
0.70x
0.75x
0.66x
0.47x
0.45x
Leverage
1.48x
1.42x
1.31x
1.25x
1.18x
1.42x
Efficiency Ratios
Analysis Summary
Metric
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Inventory Days
72.7
68.0
66.9
81.1
94.4
60.6
Receivable Days
57.9
39.7
46.8
47.2
42.5
63.7
Payable Days
100.9
94.4
87.5
79.7
65.9
74.4
Cash Conversion Cycle
29.7
13.2
26.3
48.7
71.0
50.0
Return Ratios
Analysis Summary
Metric
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
ROE
44.58%
35.78%
33.52%
25.21%
15.87%
14.20%
ROCE
50.21%
40.76%
45.92%
33.41%
21.22%
18.44%
ROA
30.07%
25.26%
25.62%
20.18%
13.46%
10.02%
Explore
Watchlists
Chat
Portfolio